Aging is a natural and inevitable part of the lifespan; it’s also at the nexus of many chronic diseases including cancer, diabetes, dementia, and more. The emerging field of geroscience is about finding the fundamental causes of aging. It may be able to delay or prevent age-related diseases as a group rather than one condition at a time. Researchers say that if the promise of geroscience is realized, a revolution in geriatric medicine may be upon us.
The wrinkle: while there are upwards of 7,000 geriatricians in the United States, only a handful are prepared to do geroscience.
“Trained geroscientists are urgently needed to facilitate clinical trials that target fundamental aging mechanisms,” says Robert Pignolo, M.D., Ph.D., chair of the division of Geriatric Medicine and Gerontology and director of the Translation and Pharmacology Program at Mayo’s Robert and Alrene Kogod Center on Aging. “Addressing this gap would accelerate our ability to bring solutions into routine patient care.”
To this end, Mayo Clinic is unveiling a first-of-its kind geroscience training program. Read the rest of the article on Discovery's Edge.
Other Mayo Clinic medical research websites: